Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Biecker

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Zeitschrift Fur Gastroenterologie|January 15, 2005
[Gastrointestinal bleeding in portal hypertension in liver cirrhosis]E Biecker, J Heller, B Appenrodt, et al.
Zeitschrift Fur Gastroenterologie|May 12, 2006
Portal hypertension and nodular regenerative hyperplasia in a patient with celiac diseaseE Biecker, J Trebicka, H-P Fischer, et al.
Der Internist|August 10, 2006
[Recurring, severe upper abdominal pain in a 45 year old patient]E Biecker, H-P Fischer, G Lutterbey, et al.
The British Journal of Surgery|May 25, 2002
Potential role of endothelin 1 in ischaemia-induced angiogenesis in critical leg ischaemiaJ C S Tsui, D M Baker, E Biecker, et al.
Angiology|September 21, 2004
Altered endothelin-1 levels in acute lower limb ischemia and reperfusionJ C S Tsui, D M Baker, E Biecker, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|April 26, 2003
Evidence for the involvement of endothelin-1 but not urotensin-II in chronic lower limb ischaemia in manJ C S Tsui, D M Baker, E Biecker, et al.
Gut|February 24, 2006
Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosisQ Zhou, M Hennenberg, J Trebicka, et al.
European Journal of Clinical Investigation|March 19, 2003
Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteriesM Neef, E Biecker, J Heller, et al.
Gastroenterology|August 7, 2001
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertensionM Schepke, E Werner, E Biecker, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Zeitschrift Fur Gastroenterologie|January 15, 2005
[Gastrointestinal bleeding in portal hypertension in liver cirrhosis]E Biecker, J Heller, B Appenrodt, et al.
Zeitschrift Fur Gastroenterologie|May 12, 2006
Portal hypertension and nodular regenerative hyperplasia in a patient with celiac diseaseE Biecker, J Trebicka, H-P Fischer, et al.
Der Internist|August 10, 2006
[Recurring, severe upper abdominal pain in a 45 year old patient]E Biecker, H-P Fischer, G Lutterbey, et al.
The British Journal of Surgery|May 25, 2002
Potential role of endothelin 1 in ischaemia-induced angiogenesis in critical leg ischaemiaJ C S Tsui, D M Baker, E Biecker, et al.
Angiology|September 21, 2004
Altered endothelin-1 levels in acute lower limb ischemia and reperfusionJ C S Tsui, D M Baker, E Biecker, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|April 26, 2003
Evidence for the involvement of endothelin-1 but not urotensin-II in chronic lower limb ischaemia in manJ C S Tsui, D M Baker, E Biecker, et al.
Gut|February 24, 2006
Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosisQ Zhou, M Hennenberg, J Trebicka, et al.
European Journal of Clinical Investigation|March 19, 2003
Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteriesM Neef, E Biecker, J Heller, et al.
Gastroenterology|August 7, 2001
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertensionM Schepke, E Werner, E Biecker, et al.
Pageof 2